Journal article
Rhenium and Technetium-oxo Complexes with Thioamide Derivatives of Pyridylhydrazine Bifunctional Chelators Conjugated to the Tumour Targeting Peptides Octreotate and Cyclic-RGDfK
AJ North, JA Karas, MT Ma, PJ Blower, U Ackermann, JM White, PS Donnelly
Inorganic Chemistry | AMER CHEMICAL SOC | Published : 2017
Abstract
This research aimed to develop new tumor targeted theranostic agents taking advantage of the similarities in coordination chemistry between technetium and rhenium. A γ-emitting radioactive isotope of technetium is commonly used in diagnostic imaging, and there are two β- emitting radioactive isotopes of rhenium that have the potential to be of use in radiotherapy. Variants of the 6-hydrazinonicotinamide (HYNIC) bifunctional ligands have been prepared by appending thioamide functional groups to 6-hydrazinonicotinamide to form pyridylthiosemicarbazide ligands (SHYNIC). The new bidentate ligands were conjugated to the tumor targeting peptides Tyr3-octreotate and cyclic-RGD. The new ligands and ..
View full abstractGrants
Awarded by European Commission
Funding Acknowledgements
Australian Research Council FT130100204 (P.S.D.). People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA Grant Agreement Number 299009 (MTM). The Centre of Excellence in Medical Engineering Centre funded by the Wellcome Trust and EPSRC (WT088641/Z/09/Z), the KCL and UCL Comprehensive Cancer Imaging Centre funded by, CRUK and EPSRC in association with the MRC and DoH (England), and the NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London.